Antiarrhythmic agents — 1987
作者： A. John Camm , Nicholas J. Linker
DOI: 10.1007/978-94-009-1081-2_23
关键词:
摘要: The drug therapy of arrhythmias has developed rapidly over the last 25 years. During this period, number available antiarrhythmic agents increased dramatically and many more compounds are in development. In United Kingdom there than forty drugs (including beta adrenergic blocking agents) currently listed pharmacopoeia. This chapter will describe some aspects newly introduced methods assessing efficacy therapy, with particular reference to arrhythmogenic effects drugs.
springer.com
sci-hub.st 参考文章(30)
H J Wellens, P Brugada, W G Stevenson, Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation. ,vol. 72, pp. 1- 7 ,(1985) , 10.1161/01.CIR.72.1.1
Anthony W. Nathan, Kevin J. Hellestrand, Rodney S. Bexton, Seamus O. Banim, Roworth A.J. Spurrell, A.John Camm, Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate. American Heart Journal. ,vol. 107, pp. 222- 228 ,(1984) , 10.1016/0002-8703(84)90368-5
S C Webb, P A Poole-Wilson, Potassium exchange in the human heart during atrial pacing and myocardial ischaemia. Heart. ,vol. 55, pp. 554- 559 ,(1986) , 10.1136/HRT.55.6.554
J.Thomas Bigger, Long-term continuous electrocardiographic recordings and electrophysiologic testing to select patients with ventricular arrhythmias for drug trials and to determine antiarrhythmic drug efficacy American Journal of Cardiology. ,vol. 58, ,(1986) , 10.1016/0002-9149(86)90106-2
Check Y Sum, Avraham Yacobi, Ronald Kartzinel, Herman Stampfli, Charles S Davis, Chii-Ming Lai, Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Clinical Pharmacology & Therapeutics. ,vol. 34, pp. 427- 434 ,(1983) , 10.1038/CLPT.1983.193
Najam Wasty, Sanjeev Saksena, Mary Joan Barr, Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study. American Heart Journal. ,vol. 110, pp. 1181- 1188 ,(1985) , 10.1016/0002-8703(85)90009-2
Maxwell J. Binder, Leon Rosove, Paroxysmal ventricular tachycardia and fibrillation due to quinidine The American Journal of Medicine. ,vol. 12, pp. 491- 497 ,(1952) , 10.1016/0002-9343(52)90229-5
Maria I. Anastasiou-Nana, Jeffrey L. Anderson, Edward M. Hampton, John N. Nanas, Barbara M. Heath, Recainam, A potent new antiarrhythmic agent: Effects on complex ventricular arrhythmias Journal of the American College of Cardiology. ,vol. 8, pp. 427- 435 ,(1986) , 10.1016/S0735-1097(86)80062-6
Richard J. Gray, Timothy M. Bateman, Lawrence S.C. Czer, Carolyn M. Conklin, Jack M. Matloff, Esmolol: A new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias Journal of the American College of Cardiology. ,vol. 5, pp. 1451- 1456 ,(1985) , 10.1016/S0735-1097(85)80362-4
Jonathan Abrams, John Allen, Douglas Allin, Jeffrey Anderson, Sharon Anderson, Lori Blanski, Kuldeep Chadda, Robert DiBianco, Laurence Favrot, Jorge Gonzalez, Leonard Horowitz, Atul Laddu, Robert Lee, Paul MacCosbe, Joel Morganroth, Onkar Narula, Bramah Singh, Jang Singh, James Steck, Charles Swerdlow, Prasad Turlapaty, Albert Waldo, Esmolol Multicenter Study Research Group, None, Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial. American Heart Journal. ,vol. 110, pp. 913- 922 ,(1985) , 10.1016/0002-8703(85)90185-1